| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.07. | Range Impact, Inc.: Range Impact Announces Vin Ferrara, MD, MBA, Has Joined the Company as Vice President, Real Estate | 495 | GlobeNewswire (Europe) | CLEVELAND, OHIO, July 08, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing former industrial... ► Artikel lesen | |
| 01.07. | Range Impact, Inc.: Range Impact and C2 Ventures Launch AI Infrastructure Platform on 9,000-Acre West Virginia Energy Corridor | 2 | GlobeNewswire (USA) | ||
| 01.07. | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| RANGE IMPACT Aktie jetzt für 0€ handeln | |||||
| 03.06. | Range Impact, Inc.: Range Impact Announces $10 Million Investment from Tacora Capital | 3 | GlobeNewswire (USA) | ||
| 03.06. | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.05. | Range Impact, Inc.: Range Impact Announces West Virginia Attorney and Business Advisor Michael Simon Has Joined the Company as a Strategic Advisor | 1 | GlobeNewswire (USA) | ||
| 18.05. | Range Impact GAAP EPS of -$0.02, revenue of $0.92M | 1 | Seeking Alpha | ||
| 15.05. | Range Impact, Inc.: Range Impact Reports 1Q 2026 Financial Results | 169 | GlobeNewswire (Europe) | CLEVELAND, OHIO, May 15, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed coal... ► Artikel lesen | |
| 15.05. | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | RANGE IMPACT, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 31.03. | Range Impact reports FY results | 1 | Seeking Alpha | ||
| 31.03. | Range Impact, Inc.: Range Impact Reports Full Year 2025 Financial Results | 468 | GlobeNewswire (Europe) | CLEVELAND, OHIO, March 30, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed... ► Artikel lesen | |
| 07.01. | Range Impact, Inc.: Range Impact Announces Two Major Land Acquisitions in Kentucky and Sale of Abandoned Mine Land Services Business | 211 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed... ► Artikel lesen | |
| 14.11.25 | Range Impact, Inc.: Range Impact Reports 3Q 2025 Financial Results | 262 | GlobeNewswire (Europe) | Cleveland, Ohio, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen | |
| 14.08.25 | Range Impact, Inc.: Range Impact Reports 2Q 2025 Financial Results | 272 | GlobeNewswire (Europe) | Cleveland, Ohio, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 40,970 | -0,06 % | Novo Nordisk, Johnson & Johnson und Co. setzen auf Plattformen - warum einzelne Medikamente für Big Pharma längst nicht mehr ausreichen | ||
| AURORA CANNABIS | 2,598 | +0,93 % | Aurora Cannabis Inc.: Aurora Cannabis Announces Fiscal 2027 First Quarter Results | NASDAQ | TSX: ACB
Delivers Net Revenue of $67.6 million, including a 17% YoY Increase in International Medical Cannabis Net Revenue
Safari Flower Company Receives Three-Year EU-GMP... ► Artikel lesen | |
| CANOPY GROWTH | 0,841 | -0,10 % | Canopy Growth übertrifft Gewinnerwartungen für Q1 2027 - Aktie legt zu | ||
| TILRAY BRANDS | 3,955 | +0,13 % | Tilray-Aktie: Startet jetzt die 700%-Chance? | Die Tilray-Aktie hat in den vergangenen Tagen eine bemerkenswerte Kehrtwende vollzogen. Nach enttäuschenden Quartalszahlen am 28. Juli geriet der Cannabis-Titel zunächst unter Druck, ehe bereits einen... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 428,40 | -0,19 % | Vertex Pharmaceuticals Inc. Profit Climbs In Q2 | CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) announced earnings for its second quarter that Increases, from the same period last yearThe company's earnings came in... ► Artikel lesen | |
| CRONOS GROUP | 2,646 | -1,19 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| DIGICANN VENTURES | 0,012 | +118,18 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| EYEPOINT | 12,100 | 0,00 % | EyePoint, Inc. - 10-Q, Quarterly Report | ||
| ORGANIGRAM GLOBAL | 0,864 | +1,77 % | Organigram Global Inc: Organigram Global to release fiscal Q3 results Aug. 11 | ||
| GREEN THUMB INDUSTRIES | 5,870 | -1,68 % | Green Thumb Industries Reports Second Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 0,292 | -9,88 % | Noveris Health Sciences Inc.: Noveris Health Sciences Inc. Unaware of Any Material Change | Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - At the request of CIRO, Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") wishes... ► Artikel lesen | |
| SANTHERA PHARMACEUTICALS | 16,940 | 0,00 % | Santhera Pharmaceuticals Holding AG: Santhera Expands Biomedica Agreement to Extend AGAMREE (Vamorolone) Distribution Across Central Asia and the Caucasus | Pratteln, Switzerland, July 13, 2026 - Santhera Pharmaceuticals (SIX: SANN) today announces an expansion of its exclusive distribution agreement with Biomedica for AGAMREE (vamorolone), extending the... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 66,00 | -0,15 % | Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis | Two global registrational Phase 3 trials initiated in ZENITH AD program
Phase 3 program based upon clinically meaningful efficacy and favorable safety data observed... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 10,140 | -2,27 % | Tonix Pharmaceuticals Q2 2026 Earnings Preview |